Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22


Reduced ceftazidime and ertapenem susceptibility due to production of OXA-2 in Klebsiella pneumoniae ST258.

Iovleva A, Mettus RT, McElheny CL, Mustapha MM, Van Tyne D, Shields RK, Pasculle AW, Cooper VS, Doi Y.

J Antimicrob Chemother. 2019 Aug 1;74(8):2203-2208. doi: 10.1093/jac/dkz183.


Small-Molecule Inhibitor of FosA Expands Fosfomycin Activity to Multidrug-Resistant Gram-Negative Pathogens.

Tomich AD, Klontz EH, Deredge D, Barnard JP, McElheny CL, Eshbach ML, Weisz OA, Wintrode P, Doi Y, Sundberg EJ, Sluis-Cremer N.

Antimicrob Agents Chemother. 2019 Feb 26;63(3). pii: e01524-18. doi: 10.1128/AAC.01524-18. Print 2019 Mar.


A Prospective Study of Acinetobacter baumannii Complex Isolates and Colistin Susceptibility Monitoring by Mass Spectrometry of Microbial Membrane Glycolipids.

Leung LM, McElheny CL, Gardner FM, Chandler CE, Bowler SL, Mettus RT, Spychala CN, Fowler EL, Opene BNA, Myers RA, Goodlett DR, Doi Y, Ernst RK.

J Clin Microbiol. 2019 Feb 27;57(3). pii: e01100-18. doi: 10.1128/JCM.01100-18. Print 2019 Mar.


Diversity of High-Level Aminoglycoside Resistance Mechanisms among Gram-Negative Nosocomial Pathogens in Brazil.

Ballaben AS, Andrade LN, Galetti R, Ferreira JC, McElheny CL, Mettus RT, da Silva P, de Oliveira Garcia D, Darini ALC, Doi Y.

Antimicrob Agents Chemother. 2018 Oct 24;62(11). pii: e01550-18. doi: 10.1128/AAC.01550-18. Print 2018 Nov. No abstract available.


Phylogenomics of colistin-susceptible and resistant XDR Acinetobacter baumannii.

Mustapha MM, Li B, Pacey MP, Mettus RT, McElheny CL, Marshall CW, Ernst RK, Cooper VS, Doi Y.

J Antimicrob Chemother. 2018 Nov 1;73(11):2952-2959. doi: 10.1093/jac/dky290.


Diversity among blaKPC-containing plasmids in Escherichia coli and other bacterial species isolated from the same patients.

Hazen TH, Mettus R, McElheny CL, Bowler SL, Nagaraj S, Doi Y, Rasko DA.

Sci Rep. 2018 Jul 6;8(1):10291. doi: 10.1038/s41598-018-28085-7.


Absence of fosfomycin resistance in gastrointestinal Escherichia coli following fosfomycin therapy.

Mettus RT, Bowler SL, Kantz SF, McElheny CL, Pasculle AW, Doi Y.

J Glob Antimicrob Resist. 2018 Sep;14:109-110. doi: 10.1016/j.jgar.2018.06.015. Epub 2018 Jun 30. No abstract available.


Draft Genome Sequences of blaKPC-Containing Enterobacter aerogenes, Citrobacter freundii, and Citrobacter koseri Strains.

Hazen TH, Mettus RT, McElheny CL, Bowler SL, Doi Y, Rasko DA.

Genome Announc. 2018 Feb 22;6(8). pii: e00035-18. doi: 10.1128/genomeA.00035-18.


Frequency and Mechanisms of Spontaneous Fosfomycin Nonsusceptibility Observed upon Disk Diffusion Testing of Escherichia coli.

Lucas AE, Ito R, Mustapha MM, McElheny CL, Mettus RT, Bowler SL, Kantz SF, Pacey MP, Pasculle AW, Cooper VS, Doi Y.

J Clin Microbiol. 2017 Dec 26;56(1). pii: e01368-17. doi: 10.1128/JCM.01368-17. Print 2018 Jan.


High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.

Guo Y, Tomich AD, McElheny CL, Cooper VS, Tait-Kamradt A, Wang M, Hu F, Rice LB, Sluis-Cremer N, Doi Y.

Emerg Infect Dis. 2017 Nov;23(11):1902-1904. doi: 10.3201/eid2311.171130.


Inhibition of Fosfomycin Resistance Protein FosA by Phosphonoformate (Foscarnet) in Multidrug-Resistant Gram-Negative Pathogens.

Ito R, Tomich AD, McElheny CL, Mettus RT, Sluis-Cremer N, Doi Y.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01424-17. doi: 10.1128/AAC.01424-17. Print 2017 Dec.


Structural modification of LPS in colistin-resistant, KPC-producing Klebsiella pneumoniae.

Leung LM, Cooper VS, Rasko DA, Guo Q, Pacey MP, McElheny CL, Mettus RT, Yoon SH, Goodlett DR, Ernst RK, Doi Y.

J Antimicrob Chemother. 2017 Nov 1;72(11):3035-3042. doi: 10.1093/jac/dkx234.


Widespread Fosfomycin Resistance in Gram-Negative Bacteria Attributable to the Chromosomal fosA Gene.

Ito R, Mustapha MM, Tomich AD, Callaghan JD, McElheny CL, Mettus RT, Shanks RMQ, Sluis-Cremer N, Doi Y.

MBio. 2017 Aug 29;8(4). pii: e00749-17. doi: 10.1128/mBio.00749-17.


Contribution of the TetB Efflux Pump to Minocycline Susceptibility among Carbapenem-Resistant Acinetobacter baumannii Strains.

Wang P, McElheny CL, Mettus RT, Shanks RMQ, Doi Y.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01176-17. doi: 10.1128/AAC.01176-17. Print 2017 Oct. No abstract available.


IncX2 and IncX1-X2 Hybrid Plasmids Coexisting in a FosA6-Producing Escherichia coli Strain.

Guo Q, Su J, McElheny CL, Stoesser N, Doi Y, Wang M.

Antimicrob Agents Chemother. 2017 Jun 27;61(7). pii: e00536-17. doi: 10.1128/AAC.00536-17. Print 2017 Jul.


Structural Modification of Lipopolysaccharide Conferred by mcr-1 in Gram-Negative ESKAPE Pathogens.

Liu YY, Chandler CE, Leung LM, McElheny CL, Mettus RT, Shanks RMQ, Liu JH, Goodlett DR, Ernst RK, Doi Y.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00580-17. doi: 10.1128/AAC.00580-17. Print 2017 Jun.


Comparison of Minocycline Susceptibility Testing Methods for Carbapenem-Resistant Acinetobacter baumannii.

Wang P, Bowler SL, Kantz SF, Mettus RT, Guo Y, McElheny CL, Doi Y.

J Clin Microbiol. 2016 Dec;54(12):2937-2941. Epub 2016 Sep 14.


In Vitro Activity of Fusidic Acid-Containing Combinations against Carbapenem-Resistant Acinetobacter baumannii Clinical Strains.

Bowler SL, Spychala CN, McElheny CL, Mettus RT, Doi Y.

Antimicrob Agents Chemother. 2016 Jul 22;60(8):5101. doi: 10.1128/AAC.01124-16. Print 2016 Aug. No abstract available.


Glutathione-S-transferase FosA6 of Klebsiella pneumoniae origin conferring fosfomycin resistance in ESBL-producing Escherichia coli.

Guo Q, Tomich AD, McElheny CL, Cooper VS, Stoesser N, Wang M, Sluis-Cremer N, Doi Y.

J Antimicrob Chemother. 2016 Sep;71(9):2460-5. doi: 10.1093/jac/dkw177. Epub 2016 Jun 3.


Comparative analysis of an IncR plasmid carrying armA, blaDHA-1 and qnrB4 from Klebsiella pneumoniae ST37 isolates.

Guo Q, Spychala CN, McElheny CL, Doi Y.

J Antimicrob Chemother. 2016 Apr;71(4):882-6. doi: 10.1093/jac/dkv444. Epub 2016 Jan 7.


Coproduction of KPC-18 and VIM-1 Carbapenemases by Enterobacter cloacae: Implications for Newer β-Lactam-β-Lactamase Inhibitor Combinations.

Thomson GK, Snyder JW, McElheny CL, Thomson KS, Doi Y.

J Clin Microbiol. 2016 Mar;54(3):791-4. doi: 10.1128/JCM.02739-15. Epub 2015 Dec 30.


Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA.

Alrowais H, McElheny CL, Spychala CN, Sastry S, Guo Q, Butt AA, Doi Y.

Emerg Infect Dis. 2015 Nov;21(11):2045-7. doi: 10.3201/eid2111.150750.

Supplemental Content

Loading ...
Support Center